This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Estee Lauder (EL) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Review Estee Lauder's (EL) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSEW
Estee Lauder (EL) Ups FY24 Profit View on Q3 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2024 results reflect higher net sales and earnings organic sales on growth across Asia travel retail. Management ups fiscal 2024 earnings view.
Private Payrolls in April Exceed Expectations
by Zacks Equity Research
Private Payrolls in April Exceed Expectations.
ADP Reports Still-Strong Labor Market; MA, EL Beat
by Mark Vickery
Off lows of late '23 and early '24, private-sector jobs growth looks to be warming up again.
Estee Lauder (EL) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Estee Lauder (EL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Estee Lauder (EL) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 102.08% and 0.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Estee Lauder Companies (EL) Ahead of Earnings?
by Zacks Equity Research
Estee Lauder Companies (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's How Clorox (CLX) is Placed Ahead of Q3 Earnings Release
by Zacks Equity Research
Clorox (CLX) third-quarter results are likely to reflect challenges related to continued impacts of the recent cyberattack incident, inflationary costs and elevated SG&A expense.
What Awaits The Estee Lauder Companies (EL) in Q3 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter performance will likely reflect strong growth across various emerging markets. However, unfavorable currency headwinds are a threat.
Unveiling Estee Lauder (EL) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Estee Lauder (EL) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Olaplex Holdings, Inc. (OLPX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Olaplex (OLPX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Estee Lauder (EL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Estee Lauder (EL) Gained But Lagged the Market Today
by Zacks Equity Research
Estee Lauder (EL) concluded the recent trading session at $148.98, signifying a +1.06% move from its prior day's close.
Estee Lauder (EL) on Track With Profit Recovery Amid Hurdles
by Zacks Equity Research
Estee Lauder (EL) is on track to operationalize the Profit Recovery Plan to focus on rebuilding stronger and more sustainable profitability alongside supporting sales growth.
Estee Lauder (EL) Gains On Online Sales & Profit Recovery Plan
by Zacks Equity Research
Estee Lauder (EL) is expanding its omnichannel capabilities to aid flexible and convenient shopping options for consumers. Management is on track to operationalize the Profit Recovery Plan.
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Coty (COTY) Up 6.7% Since Last Earnings Report?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
by Zacks Equity Research
Sector ETF report for RSPS
Estee Lauder (EL) Up 0.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPS
Estee Lauder's (EL) Online & Emerging Market Sales Aid Growth
by Zacks Equity Research
The Estee Lauder Companies (EL) is on track to expand its reach across high-growth channels and push brands into new countries. However, persistent challenges in Mainland China hurt.
Zacks Industry Outlook Highlights Estee Lauder, Coty, Inter Parfums, and Helen of Troy
by Zacks Equity Research
Estee Lauder, Coty, Inter Parfums, and Helen of Troy have been highlighted in this Industry Outlook article.
4 Cosmetics Stocks Worth Watching on Robust Industry Trends
by Ansuiya Mohta
The Zacks Cosmetics industry companies are benefiting from a burgeoning demand for skincare and personal care products. Focus on innovations is propelling The Estee Lauder Companies (EL), COTY, Inter Parfums (IPAR) and Helen of Troy (HELE).